These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 15575031)

  • 21. Impact of patient and plan design factors on switching to preferred statin therapy.
    Cox ER; Kulkarni A; Henderson R
    Ann Pharmacother; 2007 Dec; 41(12):1946-53. PubMed ID: 17971409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stats & facts. More consumer cost sharing in pharmacy benefit.
    Manag Care Interface; 2002 Apr; 15(4):34-5. PubMed ID: 11979701
    [No Abstract]   [Full Text] [Related]  

  • 23. Personal formularies. An index of prescribing quality?
    Robertson J; Fryer JL; O'Connell DL; Smith AJ; Henry DA
    Eur J Clin Pharmacol; 2001 Jul; 57(4):333-41. PubMed ID: 11549213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sources of regional variation in Medicare Part D drug spending.
    Donohue JM; Morden NE; Gellad WF; Bynum JP; Zhou W; Hanlon JT; Skinner J
    N Engl J Med; 2012 Feb; 366(6):530-8. PubMed ID: 22316446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prescription drug formularies in managed care: concerns for the elderly population.
    Gross DJ
    Clin Ther; 1998; 20(6):1277-91. PubMed ID: 9916619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incentive-based formularies.
    Thomas CP
    N Engl J Med; 2003 Dec; 349(23):2186-8. PubMed ID: 14657424
    [No Abstract]   [Full Text] [Related]  

  • 27. Managing drug costs: the perception of managed care pharmacy directors.
    Litton LM; Sisk FA; Akins ME
    Am J Manag Care; 2000 Jul; 6(7):805-14. PubMed ID: 11067377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective strategies for managing pharmacy benefits.
    Jacobson D
    Healthc Financ Manage; 2001 Mar; 55(3):41-2. PubMed ID: 11258270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence.
    Shirneshan E; Kyrychenko P; Matlin OS; Avila JP; Brennan TA; Shrank WH
    J Clin Pharm Ther; 2016 Feb; 41(1):64-9. PubMed ID: 26778812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a three-tier prescription copay on pharmaceutical and other medical utilization.
    Motheral B; Fairman KA
    Med Care; 2001 Dec; 39(12):1293-304. PubMed ID: 11717571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physicians' opinions about responsibility for patient out-of-pocket costs and formulary prescribing in two Midwestern states.
    Khan S; Sylvester R; Scott D; Pitts B
    J Manag Care Pharm; 2008 Oct; 14(8):780-9. PubMed ID: 18983207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coverage of New Drugs in Medicare Part D.
    Naci H; Kyriopoulos I; Feldman WB; Hwang TJ; Kesselheim AS; Chandra A
    Milbank Q; 2022 Jun; 100(2):562-588. PubMed ID: 35502786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. United States pharmacopeia development of the Medicare model formulary guidelines.
    Bielory L;
    Am J Geriatr Cardiol; 2005; 14(6):301-7. PubMed ID: 16276127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in managed care drug formularies: what can consumers learn?
    Schweitzer SO
    Med Care Res Rev; 2000 Sep; 57(3):326-39. PubMed ID: 10981188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Personal Formularies of Primary Care Physicians Across 4 Health Care Systems.
    Galanter W; Eguale T; Gellad W; Lambert B; Mirica M; Cashy J; Salazar A; Volk LA; Falck S; Shilka J; Van Dril E; Jarrett J; Zulueta J; Fiskio J; Orav J; Norwich D; Bennett S; Seger D; Wright A; Linder JA; Schiff G
    JAMA Netw Open; 2021 Jul; 4(7):e2117038. PubMed ID: 34264328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Maine's Medicaid drug formulary change on non-Medicaid markets: spillover effects of a restrictive drug formulary.
    Wang YR; Pauly MV; Lin YA
    Am J Manag Care; 2003 Oct; 9(10):686-96. PubMed ID: 14572179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incentive formularies and changes in prescription drug spending.
    Landon BE; Rosenthal MB; Normand SL; Spettell C; Lessler A; Underwood HR; Newhouse JP
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):360-9. PubMed ID: 17567237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specialty pharmacy management adjusts to new financial realities.
    Reinke T
    Manag Care; 2013 Apr; 22(4):13-4. PubMed ID: 23678558
    [No Abstract]   [Full Text] [Related]  

  • 40. Constraints on Formulary Design Under the Affordable Care Act.
    Andersen M
    Health Econ; 2017 Dec; 26(12):e160-e178. PubMed ID: 28233420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.